Nkarta (NKTX) Change in Acquisitions & Divestments (2020 - 2026)
Nkarta (NKTX) posted quarterly Change in Acquisitions & Divestments of $70.6 million for Q1 2026, down 6.4% year-over-year from $75.4 million in Q1 2025, and down 24.15% quarter-over-quarter from $93.1 million in Q4 2025.
Nkarta (NKTX) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Nkarta's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $70.6 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments fell 6.4% year-over-year to $70.6 million; the TTM figure through Mar 2026 stood at $335.3 million (up 13.66% YoY), while the FY2025 annual figure was $340.1 million, up 20.93% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $70.6 million, down from $93.1 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $126.0 million in Q1 2023, with the low at $29.2 million in Q1 2022.
- The 5-year median for Change in Acquisitions & Divestments is $75.4 million (2025), against an average of $76.9 million.
- The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments plunged 53.69% in 2022, then surged 331.41% in 2023.
- Nkarta's Change in Acquisitions & Divestments stood at $115.4 million in 2022, then decreased by 25.45% to $86.0 million in 2023, then fell by 4.3% to $82.3 million in 2024, then advanced by 13.1% to $93.1 million in 2025, then decreased by 24.15% to $70.6 million in 2026.
- Business Quant data shows NKTX's Change in Acquisitions & Divestments at $70.6 million in Q1 2026, $93.1 million in Q4 2025, and $83.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.70 Mn |
| Jun 30, 2026 | 63.70 Mn |
| Mar 31, 2026 | 70.61 Mn |
| Mar 31, 2026 | 70.61 Mn |
| Dec 31, 2025 | 93.08 Mn |
| Dec 31, 2025 | 93.08 Mn |
| Sep 30, 2025 | 83.16 Mn |
| Sep 30, 2025 | 83.16 Mn |
| Jun 30, 2025 | 88.42 Mn |
| Jun 30, 2025 | 88.42 Mn |
| Mar 31, 2025 | 75.44 Mn |
| Mar 31, 2025 | 75.44 Mn |
| Dec 31, 2024 | 82.30 Mn |
| Dec 31, 2024 | 82.30 Mn |
| Sep 30, 2024 | 68.23 Mn |
| Sep 30, 2024 | 68.23 Mn |
| Jun 30, 2024 | 69.00 Mn |
| Jun 30, 2024 | 69.00 Mn |
| Mar 31, 2024 | 61.70 Mn |
| Mar 31, 2024 | 61.70 Mn |